首页 | 本学科首页   官方微博 | 高级检索  
     


Effects of sea buckthorn oil intake on vaginal atrophy in postmenopausal women: A randomized,double-blind,placebo-controlled study
Authors:Petra S. Larmo,Baoru Yang,Juha Hyssä    ,Heikki P. Kallio,Risto Erkkola
Affiliation:1. Aromtech Ltd, Tornio, Finland;2. Food Chemistry and Food Development, Department of Biochemistry, University of Turku, Finland;3. Statfinn Ltd, Turku, Finland;4. Department of Obstetrics and Gynecology, University Central Hospital of Turku, Finland
Abstract:

Background

Vaginal atrophy, the thinning and drying of vaginal mucosa, is associated with menopause. The standard estrogen treatment is not suitable for all women.

Objective

To investigate the effects of oral sea buckthorn (SB) oil supplementation on vaginal atrophy.

Method

A total of 116 postmenopausal women experiencing symptoms of vaginal dryness, itching or burning were randomized to this placebo-controlled, double-blind study. Ninety-eight participants completed the intervention of three months, during which they consumed 3 g of SB or placebo oil daily. At the beginning and end, factors of vaginal health were scored by a gynecologist, vaginal pH and moisture were measured and vaginal health index was calculated. Symptoms of atrophy and menopause were evaluated at study visits and by daily logbooks. Serum samples were collected for the analysis of circulating lipids, liver enzymes and C-reactive protein.

Results

Compared to placebo, there was a significantly better rate of improvement in the integrity of vaginal epithelium in the SB group when both compliant and noncompliant participants were included (odds ratio (OR) = 3.1, 95% CI 1.11–8.95). A beneficial trend was observed when only the compliant participants were included (OR = 2.9; 95% CI 0.99–8.35). There was a tendency (P = 0.08) toward better improvement of vaginal health index from baseline to the end in the SB group [(0.8 (SD 2.8)] compared to placebo [−0.1 (SD 2.0)].

Conclusions

SB oil showed beneficial effects on vaginal health, indicating it is a potential alternative for mucosal integrity for those women not able to use estrogen treatment for vaginal atrophy.
Keywords:ALA, α-linolenic acid   ALT, alanine aminotransferase   AST, aspartate aminotransferase   BL, baseline   CI, confidence interval   CRP, C-reactive protein   EPA, eicosapentaenoic acid   HDL, high density lipoprotein   ITT, intention to treat   LA, linoleic acid   LDL, low density lipoprotein   MI, maturation index   OR, odds ratio   PP, per protocol   Q1, lower quartile   Q3, upper quartile   SD, standard deviation   SB, sea buckthorn   VagHI, vaginal health index
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号